139 related articles for article (PubMed ID: 7566367)
1. Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain.
Makar TK; Cooper AJ; Tofel-Grehl B; Thaler HT; Blass JP
Neurochem Res; 1995 Jun; 20(6):705-11. PubMed ID: 7566367
[TBL] [Abstract][Full Text] [Related]
2. Carnitine acyltransferases are not changed in Alzheimer disease.
Maurer I; Zierz S; Möller HJ
Alzheimer Dis Assoc Disord; 1998 Jun; 12(2):71-6. PubMed ID: 9651134
[TBL] [Abstract][Full Text] [Related]
3. Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease.
Kalaria RN; Harik SI
Ann Neurol; 1992 Oct; 32(4):583-6. PubMed ID: 1456745
[TBL] [Abstract][Full Text] [Related]
4. Carnitine and derivatives in the central nervous system of chick embryo.
Chiodi P; Ciani B; Kentroti S; Maccari F; Vernadakis A; Angelucci L; Ramacci MT
Int J Biochem; 1994 May; 26(5):711-20. PubMed ID: 8005356
[TBL] [Abstract][Full Text] [Related]
5. Brain oxidative stress: detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy.
Mandal PK; Tripathi M; Sugunan S
Biochem Biophys Res Commun; 2012 Jan; 417(1):43-8. PubMed ID: 22120629
[TBL] [Abstract][Full Text] [Related]
6. Microdetermination of (-)carnitine and carnitine acetyltransferase activity.
Parvin R; Pande SV
Anal Biochem; 1977 May; 79(1-2):190-201. PubMed ID: 869176
[No Abstract] [Full Text] [Related]
7. Muscle carnitine acetyltransferase and carnitine deficiency in a case of mitochondrial encephalomyopathy.
Melegh B; Seress L; Bedekovics T; Kispál G; Sümegi B; Trombitás K; Méhes K
J Inherit Metab Dis; 1999 Oct; 22(7):827-38. PubMed ID: 10518284
[TBL] [Abstract][Full Text] [Related]
8. Serum and tissue carnitine assay based on dialysis.
Shihabi ZK; Oles KS; McCormick CP; Penry JK
Clin Chem; 1992 Aug; 38(8 Pt 1):1414-7. PubMed ID: 1643708
[TBL] [Abstract][Full Text] [Related]
9. Carnitine acetyltransferase activity is not changed with age in rat brain and human platelets.
Moret C; Pastrie I; Briley M
Neurobiol Aging; 1990; 11(1):57-9. PubMed ID: 2325817
[TBL] [Abstract][Full Text] [Related]
10. Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease.
Ikeda M; Mackay KB; Dewar D; McCulloch J
Brain Res; 1993 Jul; 616(1-2):211-7. PubMed ID: 8395303
[TBL] [Abstract][Full Text] [Related]
11. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease.
Perry TL; Yong VW; Bergeron C; Hansen S; Jones K
Ann Neurol; 1987 Apr; 21(4):331-6. PubMed ID: 3579218
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease.
Rubio JC; de Bustos F; Molina JA; Jiménez-Jiménez FJ; Benito-León J; Martín MA; Campos Y; Ortí-Pareja M; Cabrera-Valdivia F; Arenas J
J Neurol Sci; 1998 Mar; 155(2):192-5. PubMed ID: 9562266
[TBL] [Abstract][Full Text] [Related]
13. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.
Aksenov MY; Tucker HM; Nair P; Aksenova MV; Butterfield DA; Estus S; Markesbery WR
J Mol Neurosci; 1998 Oct; 11(2):151-64. PubMed ID: 10096042
[TBL] [Abstract][Full Text] [Related]
14. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-coenzyme A hydrolase, an artifact? The conversion of acetyl-coenzyme A into acetate by the combined action of carnitine acetyltransferase and acetylcarnitine hydrolase.
Costa ND; Snoswell AM
Biochem J; 1975 Nov; 152(2):167-72. PubMed ID: 1220678
[TBL] [Abstract][Full Text] [Related]
16. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
[TBL] [Abstract][Full Text] [Related]
17. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.
Lovell MA; Ehmann WD; Butler SM; Markesbery WR
Neurology; 1995 Aug; 45(8):1594-601. PubMed ID: 7644059
[TBL] [Abstract][Full Text] [Related]
18. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.
Hock C; Heese K; Hulette C; Rosenberg C; Otten U
Arch Neurol; 2000 Jun; 57(6):846-51. PubMed ID: 10867782
[TBL] [Abstract][Full Text] [Related]
19. Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum.
Mohanakrishnan P; Fowler AH; Vonsattel JP; Jolles PR; Husain MM; Liem P; Myers L; Komoroski RA
J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B111-7. PubMed ID: 9060968
[TBL] [Abstract][Full Text] [Related]
20. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.
Sabbagh MN; Reid RT; Corey-Bloom J; Rao TS; Hansen LA; Alford M; Masliah E; Adem A; Lloyd GK; Thal LJ
J Neural Transm (Vienna); 1998; 105(6-7):709-17. PubMed ID: 9826113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
